SCHEMBL14402632

SCHEMBL14402632

OCCn1nc(Nc2cccc(C(F)(F)F)c2)cc1-c1cccnc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KIF11 P52732 1/20 0.52
▸ KMT2A Q03164 3/20 0.43
▸ MEN1 O00255 2/20 0.43
▸ TSHR P16473 1/20 0.43
▸ AURKA O14965 5/20 0.43
▸ TRPV4 Q9HBA0 1/20 0.42
▸ TDP1 Q9NUW8 1/20 0.42
▸ NTRK1 P04629 3/20 0.42
▸ NTRK2 Q16620 1/20 0.42
▸ IDH2 P48735 6/20 0.41
▸ CTSC P53634 3/20 0.41
▸ CLK1 P49759 3/20 0.41
▸ DYRK1A Q13627 3/20 0.41
▸ ESYT2 A0FGR8 2/20 0.41
▸ NBAS A2RRP1 2/20 0.41
▸ CNOT1 A5YKK6 2/20 0.41
▸ TBKBP1 A7MCY6 2/20 0.41
▸ AGPS O00116 2/20 0.41
▸ MYO1F O00160 2/20 0.41
▸ SNAP23 O00161 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL861455 0.84 KIF11 (0.52) KIF11KMT2AMEN1TSHRAURKA
SCHEMBL827669 0.75 IDH2 (0.47) KIF11AURKAIDH2CTSCLMNA
SCHEMBL13887208 0.72 KIF11 (0.63) KIF11KMT2AMEN1TSHRAURKA
SCHEMBL5489647 0.70 KIF11 (0.60) KIF11KMT2AMEN1TSHRAURKA
SCHEMBL9217042 0.69 CTSC (0.44) AURKAIDH2CTSC
SCHEMBL827670 0.69 AURKA (0.46) AURKAIDH2CTSCMTORGSK3B
SCHEMBL16332502 0.69 FYN (0.65) KIF11KMT2AMEN1TSHRAURKA
SCHEMBL827730 0.68 CLK1 (0.51) KMT2AMEN1IDH2CLK1DYRK1A
SCHEMBL9014180 0.67 ABL1 (0.68) KIF11AURKACTSCCLK1DYRK1A
SCHEMBL21749289 0.66 PDK2 (0.50) FGFR1DDR2ALDH1A1MERTKPDK3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007118903-A1 TRISUBSTITUTED 1,2,4-TRIAZOLES JANSSEN PHARMACEUTICA N.V. (BE) 2007-10-25 — — WO disclosed
Send feedback